Financial Projections - The estimated net profit for 2025 is projected to be between RMB 120 million and RMB 160 million, representing a year-on-year increase of 114.53% to 186.05% compared to RMB 55.93 million in the previous year[3] - The estimated net profit after deducting non-recurring gains and losses is projected to be between RMB 112 million and RMB 152 million, reflecting a year-on-year growth of 66.03% to 125.32% compared to RMB 67.46 million in the previous year[3] - The estimated impact of non-recurring gains and losses on the net profit attributable to shareholders is approximately RMB 8 million, primarily from government subsidies[6] - The performance forecast has not been audited by the accounting firm, and specific financial data will be disclosed in the 2025 annual report[7] Business Performance Drivers - The significant growth in performance is driven by the company's proactive market opportunities, expanded customer channels, and enhanced management efficiency[5] - The company has optimized its product structure and improved market layout, leading to increased revenue and gross profit in its non-sartan and formulation businesses[6] - The company has effectively reduced losses by significantly cutting back on foreign exchange derivative trading[6] Investor Guidance - The company emphasizes the importance of cautious decision-making and awareness of investment risks for investors[7]
天宇股份(300702) - 2025 Q4 - 年度业绩预告